Sanjivani Paranteral Limited (BOM:531569)

India flag India · Delayed Price · Currency is INR
170.55
+0.55 (0.32%)
At close: Mar 9, 2026
-35.50%
Market Cap 2.10B
Revenue (ttm) 736.34M
Net Income (ttm) 82.71M
Shares Out 12.28M
EPS (ttm) 6.60
PE Ratio 25.82
Forward PE n/a
Dividend 0.50 (0.29%)
Ex-Dividend Date Sep 19, 2025
Volume 18,413
Average Volume 5,303
Open 168.00
Previous Close 170.00
Day's Range 166.00 - 185.25
52-Week Range 161.00 - 278.00
Beta -1.02
RSI 33.15
Earnings Date Feb 13, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 40
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531569
Full Company Profile

Financial Performance

In fiscal year 2025, Sanjivani Paranteral's revenue was 700.99 million, an increase of 28.83% compared to the previous year's 544.11 million. Earnings were 80.97 million, an increase of 31.34%.

Financial Statements

News

Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

20 days ago - GuruFocus

Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

3 months ago - GuruFocus